U.S. Biotech Stock News

CRH plc has decided to fully delist its ordinary and preference shares from the London Stock Exchange, concentrating trading on the New York Stock Exchange after reviewing London trading activity, costs, and regulatory burdens, while also continuing a US$300 million share buyback program announced in February 2026. This latest move both underlines CRH’s operational and earnings tilt toward North America and adds to the growing list of major companies retreating from UK equity markets. We’ll...

If you are wondering whether Cushman & Wakefield is priced attractively at today’s levels, starting with a clear view of valuation can help you frame that question with more confidence. The stock last closed at US$12.13, with returns of 2.0% over 7 days, a 1.6% decline over 30 days, a 23.4% decline year to date, a 14.8% gain over 1 year, a 24.2% gain over 3 years and a 25.6% decline over 5 years, so the experience for shareholders has been very mixed across different time frames. Recent news...

In March 2026, Navitas Semiconductor unveiled a new GaNFast-based 800 V-to-6 V DC-DC power delivery board that removes the traditional 48 V intermediate bus stage, aiming to boost efficiency, reliability, and board space utilization for NVIDIA’s evolving AI data center infrastructure. This move highlights how advances in high-voltage direct conversion can reshape data center power architectures as AI compute racks push toward much higher power densities. We’ll now examine how Navitas’ 800...

Why Air Lease Is On Investors’ Radar Today Air Lease (AL) has drawn attention after recent share performance data showed small moves over the past week and month, alongside a 1 year total return above 30% and solid multi year gains. See our latest analysis for Air Lease. At around $64.58, the recent share price has been fairly steady over the past quarter. A 1 year total shareholder return of 38.15% and 3 year total shareholder return of 85.84% point to stronger momentum over a longer horizon...

Earlier this month, Workday launched “Sana from Workday,” a superintelligence AI platform that embeds conversational agents into core HR and finance workflows, while partners like AppZen and Incredible Health announced certified integrations that extend autonomous auditing and AI-driven recruiting inside the Workday ecosystem. This wave of AI product releases and partner integrations, alongside Aneel Bhusri’s return as CEO, signals Workday’s intent to make AI-native automation central to how...

Whirlpool: Recent Returns Put Valuation in Focus Whirlpool (WHR) has drawn investor attention after a recent share price slide, with the stock showing a 38% decline over the past month and a 39% negative total return over the past year. See our latest analysis for Whirlpool. That 37.8% 1 month share price decline, alongside a 27.2% year to date share price fall and a 39.0% 1 year total shareholder return loss, points to fading momentum as investors reassess Whirlpool’s risk and earnings...

DocuSign, Inc. recently reported past fourth-quarter and full-year results to 31 January 2026, with revenue of US$836.86 million for the quarter and US$3.22 billion for the year, alongside net income of US$90.3 million and US$309.09 million respectively, and issued new revenue guidance for the quarter to 30 April 2026 and the year to 31 January 2027. The company also expanded its capital return and financing toolkit, filing a US$564.32 million shelf registration tied to employee stock plans...

Why Avista (AVA) is on investors’ radar today Avista (AVA) shares recently closed at $39.54, with the stock showing mixed short term moves, including a small 1 day decline and a negative return over the past month. Over the past 3 months, Avista has delivered a positive total return. The past year and 3 year total returns are also in positive territory, which may prompt investors to compare these outcomes with other regulated utilities. See our latest analysis for Avista. After a soft 1 month...

Event context and recent return profile Elanco Animal Health (ELAN) has drawn investor attention after a strong 1 year total return of 137.4%, alongside gains of 11.5% year to date and 12.6% over the past 3 months. See our latest analysis for Elanco Animal Health. At a share price of $25.12, Elanco’s recent 7 day share price return of 10.76% and 90 day share price return of 12.65% sit on top of a 1 year total shareholder return of 137.43%. This points to strong positive momentum rather than a...

Atlassian (TEAM) is back in focus for investors after recent share price swings, with the stock showing a loss of around 9% over the past month and a deeper decline across the past 3 months. See our latest analysis for Atlassian. Those recent 1 month and 3 month share price declines sit alongside a much steeper year to date share price return of around 52% in the red. The 1 year total shareholder return is also deeply negative, suggesting momentum has been fading as investors reassess growth...

Wondering if Calix at around US$50.63 is offering good value right now, or if the easy money has already been made. The stock is up 41.9% over the past year, even though the year to date return sits at a 5.5% decline and the 30 day return is a 3.2% decline. Recent news coverage has focused on Calix as a communications technology player whose share price has moved sharply over the last year, with investors reacting to shifting expectations about its growth and competitive position. Headlines...

Wondering if ArriVent BioPharma at around US$22.86 is offering fair value, or if the market is missing something in this biotech story? The stock has had a mixed run, with a 5.1% decline over the last week, a 0.4% return over the past month, and a 9.9% gain year to date, contributing to a 17.0% return over the last year. Recent attention on ArriVent BioPharma has centered on its position within the biotech space and how its pipeline prospects and funding profile compare with peers. This...

First Interstate BancSystem (FIBK) shares closed at $32.28, with recent returns mixed across different timeframes. This may prompt investors to reassess the bank’s valuation, profitability profile and income potential. See our latest analysis for First Interstate BancSystem. The recent 15% 30 day share price decline and softer year to date return contrast with a 20% 1 year total shareholder return, suggesting near term momentum has cooled while longer term holders have still come out...

In recent months, J.B. Hunt Transport Services reported operating margin expansion to 8.0% from 6.6% year over year, with operating income up 19%, supported by intermodal strength, cost initiatives, and sizeable 2025 share repurchases of about US$923.00 million. An interesting angle is the contrast between improved intermodal efficiency and 95% customer retention on one hand, and ongoing uncertainty around the weaker Final Mile Services segment on the other. With these margin gains and...

If you are wondering whether Northrop Grumman's current share price still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you might reasonably expect to get. With the stock at US$714.15 after a 21.9% return year to date and 48.3% over the last year, recent moves have sharpened the question of whether the current valuation still looks appealing or is becoming more demanding. Recent headlines...

TriNet Group's Board has approved an increase in the company's dividend. The new dividend level reflects management's view of TriNet Group's current financial position. This decision comes with TriNet Group (NYSE:TNET) shares trading at $36.83. For investors watching NYSE:TNET, the dividend move comes during a challenging share price record. The stock is at $36.83, with returns showing a 1.9% gain over the past 7 days but declines of 11.8% over 30 days, 35.6% year to date, 52.5% over 1...

In its latest reported results, ACM Research delivered record annual revenue but saw a sharp gross margin contraction tied to product mix and competition, which contributed to an earnings miss. Despite these profitability pressures and ongoing China-related headwinds, management reiterated its ambition to reach a long-term revenue target of US$4.00 billion. We’ll now explore how the margin setback, despite record sales, may influence ACM Research’s previously optimistic investment...

Recent earnings performance and what triggered investor attention Power Solutions International (PSIX) moved onto investors’ radar after reporting third quarter sales growth of 62% year over year and earnings that exceeded analyst expectations by about 22% to 23%. See our latest analysis for Power Solutions International. Despite recent earnings strength, the 1 month share price return of 42.13% and 7 day share price return of 10.35% decline suggest momentum has cooled, even though the 1 year...

Why this earnings beat and board reshuffle matter for Sotera Health (SHC) Sotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand for its mission critical services and disciplined financial management, while also refreshing its board with a new independent director. See our latest analysis for Sotera Health. At a share price of US$13.56, Sotera Health has seen a 1 month share price return of around 21% decline and a 90 day share price...

Institutional buying sparks new attention on MoonLake Immunotherapeutics Cormorant Asset Management’s recent SEC filing, showing a purchase of over 2.3 million MoonLake Immunotherapeutics (NasdaqCM:MLTX) shares for an estimated US$27.86 million, has put the clinical stage biotech back on investor watchlists. See our latest analysis for MoonLake Immunotherapeutics. MoonLake’s recent 2.8% 1 day share price return to US$16.68 comes after a sharp sell off last year, with a 1 year total...

Recent research on First Solar (FSLR) has highlighted policy uncertainties and permitting delays weighing on its 2026 sales outlook, even as U.S. incentives and demand for domestically produced, non China solar modules support investor interest. See our latest analysis for First Solar. At a share price of US$199.65, First Solar has seen a 1 day share price return of 0.93% and a 90 day share price return decline of 25.22%. The 1 year total shareholder return of 55.42% contrasts with a 3 year...

What Enphase’s new partnerships could mean for investors Enphase Energy (ENPH) has put partnerships at the center of its next phase in energy storage, working with Ensol in France and several US partners to expand residential batteries and virtual power plants. See our latest analysis for Enphase Energy. Recent partnerships around IQ Batteries and virtual power plants come as Enphase’s share price shows mixed momentum, with a 34.26% 90 day share price return alongside a 27.64% 1 year total...

Bullish (NYSE:BLSH) has joined Midnight Foundation's node operator alliance, supporting the rollout of the Kūkolu blockchain network. The company will act as a federated node operator for the upcoming privacy focused mainnet alongside partners such as Worldpay. The collaboration positions Bullish within the early governance and technical operation of the new blockchain ecosystem. Bullish enters this alliance with its shares at $39.6 and recent returns of 9.3% over the past week and 23.8%...

AvePoint (AVPT) put its AvePoint AgentPulse Command Center into general availability, expanding multicloud observability for Google Cloud and Microsoft 365. The move is aimed at AI agent governance, data security, and enterprise cost control. See our latest analysis for AvePoint. The AgentPulse launch comes as AvePoint’s 1 year total shareholder return shows a decline of around 31%, while the 3 year total shareholder return is more than double. Recent 90 day share price weakness suggests...